Genomic Surveillance of Salmonella Paratyphi A: Neglected No More? [PDF]
Hooda Y, Tanmoy AM, Saha SK, Saha S.
europepmc +1 more source
Isolation of Salmonella paratyphi A from a patient with nephrolithiases
We describe a case of Salmonella paratyphi A isolated from urine of a 37-year-old Saudi patient who is a known case of nephrolithiasis and hydronephrosis with frequent admission for management of renal stones. History of enteric fever was not documented and urinary schistosomiasis in such a patient from endemic area is a strong possibility.
openaire +2 more sources
Salmonella paratyphi-induced splenic vein thrombosis: A case report on infrequent cause of acute abdomen. [PDF]
Saini R +4 more
europepmc +1 more source
Background: In recent years, global concern over increasing multidrug resistance (MDR) among various Salmonella serotypes has grown significantly. However, reports on MDR Salmonella Paratyphi B remain scarce, let alone the extensively drug-resistant (XDR)
Jiefu Peng +6 more
doaj +1 more source
The genomic characterization of Salmonella Paratyphi A from an outbreak of enteric fever in Vadodara, India. [PDF]
Pereira-Dias J +9 more
europepmc +1 more source
Genetic diversity of Salmonella Paratyphi A isolated from enteric fever patients in Bangladesh from 2008 to 2018. [PDF]
Rahman SIA +9 more
europepmc +1 more source
Case report of infective spondylodiscitis due to nalidixic acid-resistant Salmonella paratyphi A. [PDF]
Das S, Bandyopadhyay R, Hansdak SG.
europepmc +1 more source
Genomic sentinel surveillance: Salmonella Paratyphi B outbreak in travellers coinciding with a mass gathering in Iraq. [PDF]
Chattaway MA +5 more
europepmc +1 more source
Evaluation of Antimicrobial Susceptibility Profile in Salmonella Typhi and Salmonella Paratyphi A: Presenting the Current Scenario in India and Strategy for Future Management. [PDF]
Veeraraghavan B +29 more
europepmc +1 more source
Accelerating clinical development of a live attenuated vaccine against Salmonella Paratyphi A (VASP): study protocol for an observer-participant-blind randomised control trial of a novel oral vaccine using a human challenge model of Salmonella Paratyphi A infection in healthy adult volunteers. [PDF]
McCann N +16 more
europepmc +1 more source

